Corporate Update – Pulmuone Co., Ltd. (017810.KS)

Pulmuone Co., Ltd. advanced modestly by 1.16 % in the 24‑hour window that closed at 08:50 AM Central Europe on Wednesday, 21 October 2026. At the close, one share traded at approximately KRW 8,470 on major exchanges. With a circulating supply of 36.9 million shares, the company’s market capitalisation stands at KRW 319.9 billion. During the most recent 24‑hour period, trading volume amounted to roughly KRW 106.3 million, reflecting a modest level of market activity.

Trading Context

  • Recent Trend: Since the end of the previous month, the share price has slipped 1.36 %, indicating a slight retracement after a period of gains.
  • Moving Average: The 200‑day simple moving average currently sits at KRW 10,861.65, a figure that sits above today’s closing level and suggests a bearish bias in the longer‑term trend.
  • 52‑Week Range: The stock’s highest price over the last year was KRW 14,140 (23 October 2025), while the lowest was KRW 8,100 (30 July 2026). Today’s price lies near the lower end of that range, highlighting a period of consolidation.

Peer Performance in the Last 24 Hours

CompanyTicker% ChangeCurrent PriceMarket Cap (KRW)P/E Ratio
Samyang000070.KS+1.11 %KRW 53,100KRW 382.4 billion–
Namyang Dairy Products003920.KS+0.25 %KRW 40,450KRW 382.8 billion34.79

While Pulmuone’s modest rise mirrors the broader upward movement of its peers, the company’s valuation metrics remain relatively modest compared to the industry. Namyang Dairy Products’ higher price‑earnings ratio suggests investors may be valuing its earnings potential more conservatively.

Company Overview

Pulmuone Co., Ltd. functions as an investment holding entity, primarily engaged in the production of natural health food through its subsidiaries. Headquartered in Chungbuk, South Korea, Pulmuone operates within the Consumer Staples sector, with a focus on the Food Products industry. The company’s strategic emphasis on health‑oriented food products positions it within a growing segment of the market that seeks natural and nutritious alternatives to conventional offerings.

Outlook

Given the current market environment and the company’s positioning in the health‑food niche, analysts anticipate that Pulmuone’s share price will continue to trade within a narrowing range until a clear catalyst—such as a new product launch, expansion into new markets, or favorable regulatory changes—propels the stock above the 200‑day moving average. Investors should monitor both macro‑economic indicators and sector‑specific developments that could influence consumer demand for natural health foods.